Glycine biosynthesis pathway

Glycine biosynthesis pathway refers to the cellular processes by which glycine, the simplest amino acid, is produced in cells. In humans and many organisms, glycine is synthesized from serine via the action of serine hydroxymethyltransferase using tetrahydrofolate as a cofactor, as well as through other routes involving threonine, choline, or glyoxylate[1][2][4][5]. The produced glycine is used for protein synthesis and serves as a one-carbon donor in folate-mediated metabolism. Glycine biosynthesis is essential for a variety of biosynthetic processes, including the synthesis of purines, tetrapyrroles (like heme), and other important biomolecules[1][2][4][5]. Unlike drug targets or individual receptor molecules, "glycine production" is a metabolic process or pathway and not itself a druggable protein or receptor, nor a standard therapeutic target[1][2][4][5]. Additional notes: "Glycine production" is not a molecule, receptor, enzyme, transporter, or gene, and thus does not conform to the typical definition of a therapeutic target. It is best classified as a biological process or metabolic pathway, and queries for this as a target should be flagged as incorrect for drug discovery or pharmacological targeting purposes[1][2][4][5].

Other names

glycine synthesis pathwayglycine productionglycine biosynthetic pathway